Span Divergent Limited- Integrated Financial Result for the year ended March 31, 2025
Awaiting price reaction for this filing.
Span Divergent Limited (formerly Span Diagnostics Ltd) reported mixed results for FY25. On a standalone basis, total income fell to Rs. 276.19 lakh from Rs. 346.42 lakh, and profit after tax dropped to Rs. 83.96 lakh from Rs. 150.98 lakh. On a consolidated basis, the picture is significantly weaker: total income declined to Rs. 1,014.85 lakh from Rs. 1,361.60 lakh, and the company swung to a loss after tax of Rs. (127.37) lakh versus a profit of Rs. 78.06 lakh in FY24. Consolidated other equity is now deeply negative at Rs. (826.86) lakh, and total equity is negative at Rs. (884.13) lakh. Auditor Y.B. Desai & Associates issued an unmodified (clean) opinion on both standalone and consolidated results. Several subsidiaries face going concern challenges, including Biospan Contamination Control Solution, whose liabilities exceed assets by Rs. 6.35 crore, and Aranya Agri Biotech LLP, whose operations have been discontinued and assets classified as held for sale.
The consolidated loss, negative net worth, and going concern issues at multiple subsidiaries raise serious concerns for shareholders despite the clean audit opinion. The standalone business remains marginally profitable but is shrinking, and the weak consolidated position could weigh on the stock sentiment.